Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to `news stories` |u:www.enterprize.cam.ac.uk.  Search for `news stories` |u:www.enterprise.cam.ac.uk instead.
51 - 70 of 178 search results for `news stories` |u:www.enterprise.cam.ac.uk or `news stories` |u:www.enterprize.cam.ac.uk
  1. Fully-matching results

  2. Nyobolt: Supercharging the electric revolution – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/nyobolt-supercharging-the-electric-revolution/
    Thumbnail for Nyobolt: Supercharging the electric revolution – Cambridge Enterprise 11 Apr 2022: Nyobolt is a University spin out from the Yusuf Hamied Department of Chemistry, commercialising a novel ultra-high power battery technology
  3. KARPAS 241 Human Monoblastic cell line

    https://www.enterprise.cam.ac.uk/reagents/karpas-241-human-monoblastic-cell-line/
    Thumbnail for KARPAS 241 Human Monoblastic cell line 9 May 2022: KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at the University of Cambridge.
  4. Sustainability, investment and the Carbon Challenge – Cambridge…

    https://www.enterprise.cam.ac.uk/video/sustainability-investment-and-the-carbon-challenge/
    Thumbnail for Sustainability, investment and the Carbon Challenge – Cambridge Enterprise 12 Oct 2022: Chris Gibbs shares his perspectives on the importance of sustainability, investing in sustainability businesses and building entrepreneurial mindsets through the Carbon Challenge.
  5. Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition…

    https://www.enterprise.cam.ac.uk/news/sparxell-wins-the-2022-chris-abell-postdoc-business-plan-competition/
    Thumbnail for Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition – Cambridge Enterprise 11 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 11 November 2022. Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition. Share:. Sparxell has won the Chris Abell Postdoc Business Plan Competition 2022, securing the £20
  6. Impact Insight video case study: Kalamna toolkit – Cambridge…

    https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-kalamna-toolkit/
    Thumbnail for Impact Insight video case study: Kalamna toolkit – Cambridge Enterprise 15 Mar 2022: Kalamna, a University of Cambridge social enterprise, has developed an innovative phonics-based toolkit for learning Arabic.
  7. CAM2 software for hearing aid fitting – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/reagents/cam2-software-for-hearing-aid-fitting/
    Thumbnail for CAM2 software for hearing aid fitting – Cambridge Enterprise 9 May 2022: CAM2 software is a package that enables hearing aids to be tailored to an individual’s needs, resulting in improved hearing quality.
  8. Cambridge joins $72.5m round launching mitochondrial therapies…

    https://www.enterprise.cam.ac.uk/news/cambridge-joins-72-5m-round-launching-mitochondrial-therapies-pioneer-pretzel/
    Thumbnail for Cambridge joins $72.5m round launching mitochondrial therapies pioneer Pretzel – Cambridge Enterprise 19 Sep 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 12 September 2022. Cambridge joins $72.5m round launching mitochondrial therapies pioneer Pretzel. Share:. a biotechnology company harnessing the intricacies of mitochondrial biology to
  9. Case study: Futures We Want – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/consultancy-services-determining-the-futures-we-want/
    Thumbnail for Case study: Futures We Want – Cambridge Enterprise 11 Apr 2022: Evidence included scientific papers, government reports, and local news articles. The close collaboration with local expert teams throughout the process brought great depth of knowledge, and ensured that visions remained focused
  10. Human CD59 monoclonal antibody YTH 53.1

    https://www.enterprise.cam.ac.uk/reagents/human-cd59-monoclonal-antibody-yth-53-1/
    Thumbnail for Human CD59 monoclonal antibody YTH 53.1 9 May 2022: Hybridoma cell line producing YTH 53.1 antibodies raised against human CD59 which are rat monoclonal antibodies of the IgG2b isotype.
  11. Human CD7 monoclonal antibody YTH 30.15

    https://www.enterprise.cam.ac.uk/reagents/human-cd7-monoclonal-antibody-yth-30-15/
    Thumbnail for Human CD7 monoclonal antibody YTH 30.15 9 May 2022: Hybridoma cell line producing YTH 30.15 antibodies raised against human CD7 which are rat monoclonal antibodies of the IgG2b isotype.
  12. BOADICEA: Calculating the risk of breast cancer – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/boadicea-calculating-the-risk-of-breast-cancer/
    Thumbnail for BOADICEA: Calculating the risk of breast cancer – Cambridge Enterprise 11 Apr 2022: BOADICEA is a platform developed by researchers at the Department of Public Health and Primary Care that calculates the risk of breast cancer.
  13. New grafting technique published in Nature - Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/research-supported-by-cambridge-enterprise-and-ceres-agri-tech-published-in-nature/
    Thumbnail for New grafting technique published in Nature - Cambridge Enterprise 16 Mar 2022: New grafting techniqe supported by Cambridge Enterprise and Ceres Agri-Tech could combat Cavendish banana disease
  14. COBRAS Concrete Bridge Assessment Program – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/reagents/cobras-concrete-bridge-assessment-program/
    Thumbnail for COBRAS Concrete Bridge Assessment Program – Cambridge Enterprise 9 May 2022: COBRAS Concrete Bridge Assessment Program is a yield-line analysis software for assessing the ultimate load capacity of concrete structures.
  15. HappyShield: A simple, elegant solution to PPE scarcity – Cambridge…

    https://www.enterprise.cam.ac.uk/case-studies/happyshield-a-simple-elegant-solution-to-ppe-scarcity/
    Thumbnail for HappyShield: A simple, elegant solution to PPE scarcity – Cambridge Enterprise 11 Apr 2022: HappyShield provides a barrier from splashes and sprays of infected bodily fluids and can be cleaned and reused indefinitely.
  16. Cambridge Enterprise leads £1m investment in cancer care management…

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-leads-1m-investment-in-cancer-care-management-device-start-up/
    Thumbnail for Cambridge Enterprise leads £1m investment in cancer care management device start-up – Cambridge Enterprise 28 Apr 2022: Cambridge Enterprise leads £1 million investment in 52 North Health, a UK and US-based med-tech start-up.
  17. Rat CD45 monoclonal antibody YTH 24.5

    https://www.enterprise.cam.ac.uk/reagents/human-cd45-monoclonal-antibody-yth-24-5/
    Thumbnail for Rat CD45 monoclonal antibody YTH 24.5 9 May 2022: Hybridoma cell line producing YTH 24.5 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.
  18. Cambridge Enterprise co-leads £2.4m investment in spin-out developing …

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-co-leads-2-4m-investment-in-spin-out-developing-adc-cancer-therapeutics/
    Thumbnail for Cambridge Enterprise co-leads £2.4m investment in spin-out developing ADC cancer therapeutics – Cambridge Enterprise 14 Jun 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 14 June 2022. Cambridge Enterprise co-leads £2.4m investment in spin-out developing ADC cancer therapeutics. Share:. Spirea Limited, a University of Cambridge spin-out company created
  19. Knowledge exchange in southern Africa – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/knowledge-exchange-teaching-and-learning-in-southern-africa/
    Thumbnail for Knowledge exchange in southern Africa – Cambridge Enterprise 11 Apr 2022: We ran a knowledge exchange programme on research commercialisation for three southern African universities in 2019.
  20. Human CD11a monoclonal antibody YTH 81.5

    https://www.enterprise.cam.ac.uk/reagents/human-cd11a-monoclonal-antibody-yth-81-5/
    Thumbnail for Human CD11a monoclonal antibody YTH 81.5 9 May 2022: Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are rat monoclonal antibodies of the IgG2a isotype.
  21. Joint Harvard-Cambridge spin-out closes $50m Series A to drive…

    https://www.enterprise.cam.ac.uk/news/joint-harvard-cambridge-spin-out-closes-50m-series-a-to-drive-biomolecular-condensate-drug-discovery/
    Thumbnail for Joint Harvard-Cambridge spin-out closes $50m Series A to drive biomolecular condensate drug discovery – Cambridge Enterprise 4 Jul 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 6 June 2022. Joint Harvard-Cambridge spin-out closes $50m Series A to drive biomolecular condensate drug discovery. Share:. a joint spin-out from the University of Cambridge and Havard

Refine your results

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.